Article info

Download PDFPDF

Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure?
  1. Correspondence to:
    Wolfram Doehner
    MD, PhD, Division of Applied Cachexia Research, Department of Cardiology, Charité, Campus Virchow-Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany ; wolfram.doehnercharite.de
View Full Text

Citation

Doehner W, Anker SD
Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure?

Publication history

  • First published May 13, 2005.
Online issue publication 
May 13, 2005

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.